There isn't a website that I can point you to for this. Think about these things:
1. SI had left Australia and lived in the USA for over 20 years early in his career. He was also on one of Obama's FDA teams back in the day. Mesoblast decided to shoot for FDA approval and he knew to put expertise and a footprint in the US, including a joint listing on the NASDAQ. Stop thinking through Australian eyes. These things start off as campaigning - it's the US of A! DO some research on how many applications the FDA get every year. Then on how many make it to trial. Then on how many are successful. There is a vetting process! Think about what CYP offer to the FDA.
2. Q1. Have you got any FDA trial experience?
3. Research the time and effort it takes to start any FDA trial. Hint: there's a company on the ASX that has done quite a few of them in the area of MSC's.
4. Research and find another Australian Company that has done what CYP 'expect' to start by the end of the year, in the manner they intend to do it. Come back here when you find one - see ya!
5. Go and look at all the (non-USA) companies that have been granted FDA approval. Most have offices and expertise in the USA even though they are based elsewhere. Why didn't they just get on Zoom?!
6. Stop buying the line that saying money in Bio is the way to go. SI is not sitting in his office secretly wishing he had begged others for cash to get the trials done.
7. Fuji walked. And they didn't look back. If CYP had a shot at the FDA, it was in a partnership with them. FF have offices in the USA - the idiots!
- Forums
- ASX - By Stock
- CYP
- Ann: Notice of Allowance for Australia & Canada Cymerus Patents
CYP
cynata therapeutics limited
Add to My Watchlist
9.09%
!
18.0¢

Ann: Notice of Allowance for Australia & Canada Cymerus Patents, page-27
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
18.0¢ |
Change
0.015(9.09%) |
Mkt cap ! $40.67M |
Open | High | Low | Value | Volume |
17.5¢ | 18.0¢ | 17.5¢ | $29.91K | 170.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 35924 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 27622 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 35924 | 0.175 |
1 | 62866 | 0.170 |
2 | 60542 | 0.165 |
2 | 27975 | 0.160 |
3 | 181290 | 0.155 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 27622 | 2 |
0.185 | 135916 | 3 |
0.190 | 66916 | 2 |
0.195 | 9659 | 3 |
0.200 | 55400 | 2 |
Last trade - 15.57pm 28/07/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online